The property was finalized in August 2020 and is currently leased by Oribalt. The parties have agreed on an expansion project of approximately 2,800 m². Upon completion (est. Q3 2023), the terminal will be approx. 9,600 m².
Oribalt Group provide a wide range of logistic services for pharmaceutical manufacturers such as warehousing, distribution, transportation, direct delivery models, as well as cold chain logistics, direct deliveries to patients, labelling and other services. Oribalt´s pre-wholesale service portfolio is adapted to customer needs and requirements across all Baltic region.